Literature DB >> 19013602

Assessment of the performance of the American Urological Association symptom score in 2 distinct patient populations.

Timothy V Johnson1, Evan D Schoenberg, Ammara Abbasi, Samantha S Ehrlich, Renee Kleris, Ashli Owen-Smith, Kristin Gunderson, Viraj A Master.   

Abstract

PURPOSE: Recent research suggests that low education and illiteracy may drive misunderstanding of the American Urological Association Symptom Score, a key tool in the American Urological Association benign prostatic hyperplasia guidelines. It is unclear whether misunderstanding is confined to patients of low socioeconomic status. Therefore, we reevaluated the prevalence and impact of this misunderstanding in a county vs university hospital population.
MATERIALS AND METHODS: This prospective study involved 407 patients from a county hospital and a university hospital who completed the American Urological Association Symptom Score as self-administered and then as interviewer administered. Responses were compared by calculating correlation coefficients and weighted kappa statistics to assess patient understanding of the American Urological Association Symptom Score. Multivariate logistic regression analyses were used to examine the association between patient characteristics and poor understanding of the American Urological Association Symptom Score.
RESULTS: Of the patients 72% understood all 7 American Urological Association Symptom Score questions. Of the measured demographic variables only education level significantly affected this understanding. Compared to patients with more than 12 years of education county hospital patients with less than 9 years of education were 57.06 times more likely to misunderstand the American Urological Association Symptom Score (95% CI 14.32-329.34) while university hospital patients with less than 9 years of education were 38.27 times more likely to misunderstand the American Urological Association Symptom Score (95% CI 1.69-867.83). Of county hospital patients 31% and of university hospital patients 21% significantly misrepresented their symptom severity according to current guidelines.
CONCLUSIONS: Patients with low education regardless of location are more likely to misunderstand the American Urological Association Symptom Score, misrepresent their symptoms and, therefore, receive inappropriate treatment.

Entities:  

Mesh:

Year:  2008        PMID: 19013602     DOI: 10.1016/j.juro.2008.09.010

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

1.  Association between socioeconomic status (SES) and lower urinary tract symptom (LUTS) severity among black and white men.

Authors:  Jay H Fowke; Heather Munro; Lisa B Signorello; William J Blot; David F Penson
Journal:  J Gen Intern Med       Date:  2011-07-01       Impact factor: 5.128

2.  Office evaluation of male patients with lower urinary tract symptoms.

Authors:  Shahin Tabatabaei; Saman Shafaat Talab; Mahdi Zangi; Henry H Woo
Journal:  Curr Urol Rep       Date:  2012-12       Impact factor: 3.092

3.  Validation of a Visual Prostate Symptom Score in Men With Lower Urinary Tract Symptoms in a Health Safety Net Hospital.

Authors:  Rachel E Selekman; Catherine R Harris; Pauline Filippou; Thomas Chi; Amjad Alwaal; Sarah D Blaschko; Benjamin N Breyer
Journal:  Urology       Date:  2015-07-10       Impact factor: 2.649

4.  Misinterpretation of the international prostate symptom score questionnaire by Indian patients.

Authors:  Tarun Jindal; Rajan Kumar Sinha; Subhabrata Mukherjee; Soumendra Nath Mandal; Dilip Karmakar
Journal:  Indian J Urol       Date:  2014-07

5.  Relationship between visual prostate score (VPSS) and maximum flow rate (Qmax) in men with urinary tract symptoms.

Authors:  Mazhar A Memon; M Hammad Ather
Journal:  Int Braz J Urol       Date:  2016 Mar-Apr       Impact factor: 1.541

6.  Luts-V: A new simplified score for assessing lower urinary tract symptoms in men.

Authors:  Caroline Santos Silva; Ueslei Menezes de Araujo; Mateus Andrade Alvaia; Kátia Santana Freitas; Taciana Leonel Nunes Tiraboschi; Cristiano Mendes Gomes; José de Bessa
Journal:  Int Braz J Urol       Date:  2021 May-Jun       Impact factor: 1.541

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.